State Of Wyoming Immuno Gen, Inc. Transaction History

State Of Wyoming

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.55 - $6.31 $22,440 - $31,120	4,932 New	4,932 $24,000
Q2 2022 Aug 15, 2022	SELL	$3.15 - $5.76 $25,811 - $47,197	-8,194 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.26 - $7.48 $15,242 - $26,763	3,578 Added 77.51%	8,194 $39,000
Q4 2021 Feb 11, 2022	BUY	$4.75 - $7.5 $13,684 - $21,607	2,881 Added 166.05%	4,616 $34,000
Q3 2021 Feb 11, 2022	SELL	$5.02 - $6.59 $6,179 - $8,112	-1,231 Reduced 41.5%	1,735 $10,000
Q2 2021 Feb 11, 2022	BUY	$5.79 - $8.6 $9,796 - $14,551	1,692 Added 132.81%	2,966 $20,000
Q1 2021 Feb 08, 2022	BUY	$6.5 - $10.53 $8,281 - $13,415	1,274 New	1,274 $10,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.